Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinorelbine Plus Gemcitabine vs Vinorelbine Plus Carboplatin in Advanced NSCLC
NCT00737867Phase 3Completed
- Sponsor
- Norwegian Lung Cancer Study Group
- Start
- Sep 2007
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Norwegian Lung Cancer Study Group. Started Sep 2007; status: completed.
02
Drugs
gemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00737867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00737867.